Literature DB >> 27131586

Depression, anxiety, and psychotropic medication use and fecundability.

Yael I Nillni1, Amelia K Wesselink2, Jaimie L Gradus3, Elizabeth E Hatch2, Kenneth J Rothman4, Ellen M Mikkelsen5, Lauren A Wise6.   

Abstract

BACKGROUND: The literature regarding the associations between depression, anxiety, and fecundity is inconsistent. While cross-sectional studies suggest that depression and/or anxiety may adversely affect fecundity, the sole cohort study showed only a small association.
OBJECTIVE: We sought to evaluate the association of self-reported depressive symptoms, self-reported diagnoses of depression and anxiety, and psychotropic medication use with fecundability in a prospective cohort study. STUDY
DESIGN: Data were derived from Pregnancy Study Online (PRESTO), an Internet-based preconception cohort study of couples attempting to conceive in the United States and Canada. At baseline, female participants completed a survey that assessed demographic information, history of physician-diagnosed depression and anxiety, self-reported depressive symptoms (assessed by the Major Depression Inventory), and use of psychotropic medications. Women completed follow-up surveys every 8 weeks for up to 12 months or until reported conception to assess changes in exposures and pregnancy status. We estimated fecundability ratios and 95% confidence intervals using proportional probabilities regression models. The analysis was restricted to 2146 women who had been attempting to conceive for ≤6 cycles at study entry.
RESULTS: Severe depressive symptoms at baseline, regardless of treatment, were associated with decreased fecundability compared with no or low depressive symptoms (fecundability ratio, 0.62; 95% confidence interval, 0.43-0.91). The fecundability ratio associated with a 10-unit increase in Major Depression Inventory score was 0.90 (95% confidence interval, 0.83-0.97). Women who reported moderate to severe depressive symptoms and had never received psychotropic medications (fecundability ratio, 0.69; 95% confidence interval, 0.48-0.99) or who were currently being treated with psychotropic medications (fecundability ratio, 0.72; 95% confidence interval, 0.44-1.20) had decreased fecundability relative to women who had no/mild depressive symptoms and had never used psychotropic medications. Former users of psychotropic medications had increased fecundability regardless of the presence of no/mild depressive symptoms (fecundability ratio, 1.22; 95% confidence interval, 1.06-1.39) or moderate to severe depressive symptoms (fecundability ratio, 1.18; 95% confidence interval, 0.80-1.76).
CONCLUSION: We found an inverse association between depressive symptoms and fecundability, independent of psychotropic medication use. Use of psychotropic medications did not appear to harm fecundability. Published by Elsevier Inc.

Entities:  

Keywords:  anxiety; depression; fecundability; psychotropic medication

Mesh:

Substances:

Year:  2016        PMID: 27131586     DOI: 10.1016/j.ajog.2016.04.022

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss.

Authors:  Lindsey A Sjaarda; Jeannie G Radoc; Kerry S Flannagan; Sunni L Mumford; Keewan Kim; Neil J Perkins; Robert M Silver; Enrique F Schisterman
Journal:  Fertil Steril       Date:  2020-10-14       Impact factor: 7.329

2.  Predictive models of pregnancy based on data from a preconception cohort study.

Authors:  Jennifer J Yland; Taiyao Wang; Zahra Zad; Sydney K Willis; Tanran R Wang; Amelia K Wesselink; Tammy Jiang; Elizabeth E Hatch; Lauren A Wise; Ioannis Ch Paschalidis
Journal:  Hum Reprod       Date:  2022-03-01       Impact factor: 6.918

Review 3.  The current situation and future directions for the study on time-to-pregnancy: a scoping review.

Authors:  Xiang Hong; Jiechen Yin; Wei Wang; Fanqi Zhao; Hong Yu; Bei Wang
Journal:  Reprod Health       Date:  2022-06-25       Impact factor: 3.355

4.  Major depression, antidepressant use, and male and female fertility.

Authors:  Emily A Evans-Hoeker; Esther Eisenberg; Michael P Diamond; Richard S Legro; Ruben Alvero; Christos Coutifaris; Peter R Casson; Gregory M Christman; Karl R Hansen; Heping Zhang; Nanette Santoro; Anne Z Steiner
Journal:  Fertil Steril       Date:  2018-05       Impact factor: 7.329

5.  Case-based care for pre-existing or new-onset mood disorders in patients undergoing infertility therapy.

Authors:  Dikea Roussos-Ross; Alice S Rhoton-Vlasak; Katherine M Baker; Brittany J Arkerson; Georgia Graham
Journal:  J Assist Reprod Genet       Date:  2018-06-02       Impact factor: 3.412

6.  The Herb-Drug Pharmacokinetic Interaction of Fluoxetine and Its Metabolite Norfluoxetine with a Traditional Chinese Medicine in Rats by LC-MS/MS.

Authors:  Lijing Yan; Sheng Wang; Linlin Zhao; Juan Qiu; Lu Zhou; Wenbo Wang; Xia Xu; Dongsheng Wang; Xinjian Qiu; Dilan Qin
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-30       Impact factor: 2.629

7.  Residential proximity to major roads and fecundability in a preconception cohort.

Authors:  Amelia K Wesselink; Kipruto Kirwa; Elizabeth E Hatch; Perry Hystad; Adam A Szpiro; Joel D Kaufman; Jonathan I Levy; Ellen M Mikkelsen; Sabah M Quraishi; Kenneth J Rothman; Lauren A Wise
Journal:  Environ Epidemiol       Date:  2020-11-11

8.  Allostatic load, a measure of chronic physiological stress, is associated with pregnancy outcomes, but not fertility, among women with unexplained infertility.

Authors:  Emily S Barrett; Wendy Vitek; Omar Mbowe; Sally W Thurston; Richard S Legro; Ruben Alvero; Valerie Baker; G Wright Bates; Peter Casson; Christos Coutifaris; Esther Eisenberg; Karl Hansen; Stephen Krawetz; Randal Robinson; Mitchell Rosen; Rebecca Usadi; Heping Zhang; Nanette Santoro; Michael Diamond
Journal:  Hum Reprod       Date:  2018-09-01       Impact factor: 6.918

Review 9.  Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance.

Authors:  Charles L Raison; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

10.  Antidepressant-Like Effects and Cognitive Enhancement of Coadministration of Chaihu Shugan San and Fluoxetine: Dependent on the BDNF-ERK-CREB Signaling Pathway in the Hippocampus and Frontal Cortex.

Authors:  Lijing Yan; Xia Xu; Zhenyu He; Sheng Wang; Linlin Zhao; Juan Qiu; Dongsheng Wang; Zhicheng Gong; Xinjian Qiu; Huiyong Huang
Journal:  Biomed Res Int       Date:  2020-02-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.